LDOS Leidos

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: Provides technology, engineering, and scientific services to government and commercial customers, with emphasis on defense, intelligence, and health sectors
• • Strategic emphasis on evolving ESG practices amid increased regulatory and stakeholder attention, driving new compliance costs and reputational risk management efforts
• • Backlog $49.0B (including $9.7B funded) as of Jan 2, 2026, with revenues dependent on contract realization and subject to government termination rights
• • Profitability risk heightened by 43% revenues from Fixed-Price contracts, requiring precise cost estimates amid inflation, subcontractor performance, and force majeure challenges
• • Noteworthy focus on operational risks from employee/subcontractor misconduct, data security lapses, and talent retention amid regulatory scrutiny and executive compensation restrictions

Risk Factors

• • Regulatory risk: Non-compliance with U.S. government procurement laws may trigger penalties including contract termination, suspension, or debarment from federal contracting
• • Macroeconomic threat: Budget Control Act of 2011 and Fiscal Responsibility Act of 2023 impose caps, risking reduced defense spending and DoW contract revenue (49% of total)
• • Supply chain vulnerability: Inflation and global supply disruptions raise costs, underpricing risk on fixed-price multi-year U.S. government contracts, pressuring profitability
• • Competitive risk: Larger competitors and federal contract research centers intensify competition, potentially reducing contract awards and market share
• • Financial risk: Revenues heavily reliant (87%) on U.S. government contracts with budget delays and continuing resolutions risking payment delays and government shutdown impacts

Management Discussion & Analysis

• • Revenue $17.174B, up 3% YoY from $16.662B driven by program wins, volume increases, and a $60M acquisition contribution
• • Operating margin 12.3% vs 11.0%; Operating income $2.109B, up 15% YoY from $1.827B
• • Best segment Health & Civil: revenue $5.069B (+1%), operating margin 23.7% vs 21.8%, operating income $1.202B (+10%); Worst segment Commercial & International: revenue $2.315B (+3%), operating margin 7.2% vs 4.6%, operating income $166M (+60%) but lowest margin
• • Cash flow from operations $1.750B (+$315M); Capital allocation includes $211M dividends, $400M open market stock repurchases, and $500M accelerated share repurchase, plus $293M acquisition cash outflow
• • Forward outlook notes risks from U.S. government spending uncertainty and competitive pressures; liquidity sufficient for next 12 months including $1.5B amended credit facility and $1.4B bridge loan for $2.4B Entrust acquisition

What are the latest LDOS SEC filings in 2026?

Leidos (LDOS) has filed a 10-K annual report on February 17, 2026, a 10-Q quarterly report on May 5, 2026, an 8-K current report on August 4, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did LDOS file its most recent 10-K annual report?

Leidos (LDOS) filed its most recent 10-K annual report on February 17, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view LDOS 10-Q quarterly reports?

Leidos (LDOS)'s most recent 10-Q quarterly report was filed on May 5, 2026. SignalX displays every LDOS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has LDOS filed recently?

Leidos (LDOS)'s most recent 8-K was filed on August 4, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find LDOS insider trading activity (Form 4)?

SignalX aggregates every LDOS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does LDOS file with the SEC?

Leidos (LDOS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new LDOS filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Leidos (LDOS).

What is LDOS's SEC CIK number?

Leidos (LDOS)'s SEC CIK (Central Index Key) number is 1336920. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1336920 to look up all LDOS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find LDOS return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Leidos (LDOS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.